|1.||Imhof, Beat A: 10 articles (10/2013 - 05/2005)|
|2.||Aurrand-Lions, Michel: 9 articles (10/2013 - 05/2005)|
|3.||Dejana, Elisabetta: 8 articles (01/2011 - 09/2004)|
|4.||Corada, Monica: 6 articles (01/2011 - 09/2004)|
|5.||Chavakis, Triantafyllos: 5 articles (10/2013 - 10/2005)|
|6.||Weber, Christian: 4 articles (02/2015 - 02/2006)|
|7.||Nourshargh, Sussan: 4 articles (10/2013 - 05/2005)|
|8.||Bidzhekov, Kiril: 3 articles (02/2015 - 08/2009)|
|9.||Koenen, Rory R: 3 articles (02/2015 - 02/2006)|
|10.||Naik, Ulhas P: 3 articles (02/2014 - 04/2008)|
09/21/2012 - "Mice lacking junctional adhesion molecule A (JAM-A, encoded by F11r) exhibit enhanced intestinal epithelial permeability, bacterial translocation, and elevated colonic lymphocyte numbers, yet do not develop colitis. "
06/01/2013 - "DSS administration also impaired TJ barrier integrity in the colon, as indicated by increased colon permeability and plasma LPS-binding protein levels, resulting from the impaired colonic expression of TJ proteins, occludin, junctional adhesion molecule-A, and claudin-3. Supplemental feeding with naringenin totally or partially attenuated these symptoms, suggesting that naringenin ameliorates the DSS-induced colitis at least partially through protection of the TJ barrier. "
|2.||Hypertension (High Blood Pressure)
05/01/2010 - "Recent studies have suggested that proinflammatory molecules, such as junctional adhesion molecule 1 (JAM-1) are highly expressed in the NTS of an animal model of human essential hypertension, the spontaneously hypertensive rat (SHR), compared with normotensive rats (Wistar-Kyoto, WKY). "
12/01/2012 - "Upregulation of junctional adhesion molecule-A is a putative prognostic marker of hypertension."
05/01/2009 - "The F11 receptor (F11R, also known as junctional adhesion molecule A (JAM-A)) plays a role in the development of hypertension in rat. "
05/01/2009 - "Elevated plasma level of soluble F11 receptor/junctional adhesion molecule-A (F11R/JAM-A) in hypertension."
12/01/2012 - "We assess dynamics of junctional adhesion molecule-A (JAM-A) expression in rat models of hypertension and test whether JAM-A expression could be driven by angiotensin (ANG) II and whether JAM-A contributes to the progression of hypertension. "
|3.||Coronary Artery Disease (Coronary Atherosclerosis)
|4.||Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/15/2013 - "A novel role for junctional adhesion molecule-A in tumor proliferation: modulation by an anti-JAM-A monoclonal antibody."
01/01/2012 - "Isolation of reovirus T3D mutants capable of infecting human tumor cells independent of junction adhesion molecule-A."
10/28/2005 - "The homophilic binding of junctional adhesion molecule-C mediates tumor cell-endothelial cell interactions."
07/01/2005 - "Antibody against junctional adhesion molecule-C inhibits angiogenesis and tumor growth."
12/01/2014 - "The aberrant expression of junctional adhesion molecule A (JAM-A), which has a close correlation with the development, progression, metastasis, and prognosis of cancer, has been frequently reported. "
|1.||Proteins (Proteins, Gene)
|10.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)